XML 49 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Share - Based Compensation (Tables)
12 Months Ended
Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of share based compensation expense The 2019 Plan, which expires in 2024, provides for granting of SARs, stock options, stock awards, cash awards, and such other awards or combination thereof as the Executive Organization and Compensation Committee or, in the case of director awards, the Corporate Governance Committee of the Board of Directors (together referred to as the Committee) may determine to officers, other key employees and members of the Board of Directors. Grants are generally made at regularly scheduled committee meetings. Compensation costs charged to expense under award programs paid (or to be paid) with shares (including SARs, stock options, performance shares, restricted stock, and RSUs) are summarized in the table below:
Year Ended June 30,
2020

 
2019

 
2018

SARs and options
$
2,954

 
$
2,440

 
$
1,961

Performance shares
854

 
2,082

 
2,006

Restricted stock and RSUs
3,146

 
2,391

 
2,660

Total compensation costs under award programs
$
6,954

 
$
6,913

 
$
6,627


Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]
The aggregate unrecognized compensation cost for share-based award programs with the potential to be paid at June 30, 2020 is summarized in the table below:
June 30,
2020

 
Average Expected Period of Expected Recognition (Years)
SARs and options
$
4,113

 
2.2
Performance shares
4,580

 
1.8
Restricted stock and RSUs
3,028

 
2.1
Total unrecognized compensation costs under award programs
$
11,721

 
2.0

Weighted-average assumptions used for SARs and stock option grants issued
The weighted-average assumptions used for SARs and stock option grants issued in fiscal 2020, 2019
and
2018 are:
 
2020

 
2019

 
2018

Expected life, in years
6.2

 
6.0

 
6.0

Risk free interest rate
1.6
%
 
2.8
%
 
2.1
%
Dividend yield
2.3
%
 
1.8
%
 
2.5
%
Volatility
23.7
%
 
22.5
%
 
24.3
%
Per share fair value of SARs granted during the year
$10.12
 
$16.15
 
$11.25

Summary of SARs and stock option activity
A summary of SARs and stock options activity is presented below:
 
Shares

 
Weighted-Average
Exercise Price

Year Ended June 30, 2020
 
(Shares in thousands)
 
Outstanding, beginning of year
1,479

 
$
49.42

Granted
296

 
54.20

Exercised
(139
)
 
39.06

Forfeited
(16
)
 
60.64

Outstanding, end of year
1,620

 
$
51.07

Exercisable at end of year
996

 
$
46.10

Expected to vest at end of year
1,607

 
$
51.01


Performance Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the performance shares and restricted stock activity
A summary of non-vested performance shares activity at June 30, 2020 is presented below:
 
Shares

 
Weighted-Average
Grant-Date  
Fair Value

Year Ended June 30, 2020
 
(Shares in thousands)
 
Non-vested, beginning of year
97

 
$
50.88

Awarded
17

 
52.86

Vested
(58
)
 
47.87

Non-vested, end of year
56

 
$
54.62


Restricted stock and Restricted Stock units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the performance shares and restricted stock activity
A summary of the status of the Company’s non-vested restricted stock and RSUs at June 30, 2020 is presented below:
 
Shares

 
Weighted-Average
Grant-Date  
Fair Value

Year Ended June 30, 2020
 
(Share amounts in thousands)
 
Non-vested, beginning of year
89

 
$
59.93

Granted
81

 
56.74

Vested
(40
)
 
53.60

Non-vested, end of year
130

 
$
59.91